AletheiaHQ
Sign In
We're live on Product Hunt! Come say hi.
DIR-E8-PAT-53P4/LVL 5·Leveraged OperationsHigh-leverage, capital-intensive cell operations. Requires fronted capital or established legal infrastructure. Examples: fronting $10k to lease warehouse space ahead of a known logistics fracture; forming a joint entity to secure and sub-license a dormant government patent for recurring royalties./85% confidence
Return to directory

Capture Military Hypoxia Monitoring via NASA Exclusive License

Organization
NASA Glenn Research Center
Sector
Defense Contractors (Lockheed Martin, Boeing, Northrop Grumman)
Location
United States

Source reference

https://technology.nasa.gov/patent/LEW-TOPS-16

// Space Commerce & Resources// Biotech// Aviation & Aircraft// Crisis Management// Import/Export// Lobbying// IP// Open-Source Intelligence

Executive summary

Current state

NASA's validated PUMA hypoxia-prediction technology with F-22 flight test data is licensable but currently only licensed for fitness applications, creating a pricing arbitrage between NASA's institutional rates and defense/commercial aviation's urgent safety needs.

Market catalyst

NASA has validated F-22 hypoxia-prediction technology priced at academic licensing rates ($5k-$50k) while defense contractors face urgent safety needs and multi-million dollar budgets for validated solutions - a 100x pricing arbitrage opportunity.

This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.

Field notes

Intelligence ledger

Shared context / revisions / signals

Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.

Sign in to add intelligence or vote on a field note.

Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.